Extending Indication for Islet Autotransplantation in Pancreatic Surgery (AutoTx)
Autologous Pancreatic Islet Cell Transplantation for Improved Glycaemic Control After Pancreatectomy: Observational Study
Sponsor: Ospedale San Raffaele
A observational or N/A phase clinical study on Diabetes, this trial is ongoing. The trial is conducted by Ospedale San Raffaele and has accumulated 15 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Mar 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Mar 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Jan 2023 — Mar 2024 [monthly]
Recruiting
▶ Show 10 earlier versions
-
Dec 2021 — Jan 2023 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Unknown Status
-
Mar 2020 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ospedale San Raffaele
For direct contact, visit the study record on ClinicalTrials.gov .